XML 36 R19.htm IDEA: XBRL DOCUMENT
v3.25.1

Goodwill | 12 Months Ended
--- | ---
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill | (9) Goodwill The following table reflects the changes in the carrying amount of goodwill by reporting unit for the years ended December 31, 2024 and 2023:
| Healthcare |  | Industrial |  | Consolidated
(in thousands) | Gross Goodwill |  | Cumulative Impairments |  | Net Goodwill |  | Gross Goodwill |  | Cumulative Impairments |  | Net Goodwill |  | Gross Goodwill |  | Cumulative Impairments |  | Net Goodwill
Balance at December 31, 2022 | $ | 143,431 |  |  | $ | (32,055) |  |  | $ | 111,376 |  |  | $ | 316,265 |  |  | $ | (42,329) |  |  | $ | 273,936 |  |  | $ | 459,696 |  |  | $ | (74,384) |  |  | $ | 385,312 |
Acquisitions | 1,005 |  |  | — |  |  | 1,005 |  |  | 7,386 |  |  | — |  |  | 7,386 |  |  | 8,391 |  |  | — |  |  | 8,391 |
Impairments | — |  |  | — |  |  | — |  |  | — |  |  | (279,808) |  |  | (279,808) |  |  | — |  |  | (279,808) |  |  | (279,808) |
Foreign currency translation adjustments | 3,701 |  |  | — |  |  | 3,701 |  |  | (1,514) |  |  | — |  |  | (1,514) |  |  | 2,187 |  |  | — |  |  | 2,187 |
Balance at December 31, 2023 | $ | 148,137 |  |  | $ | (32,055) |  |  | $ | 116,082 |  |  | $ | 322,137 |  |  | $ | (322,137) |  |  | $ | — |  |  | $ | 470,274 |  |  | $ | (354,192) |  |  | $ | 116,082 |
Impairments | — |  |  | (101,445) |  |  | (101,445) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (101,445) |  |  | (101,445) |
Foreign currency translation adjustments | 242 |  |  | — |  |  | 242 |  |  | — |  |  | — |  |  | — |  |  | 242 |  |  | — |  |  | 242 |
Balance at December 31, 2024 | $ | 148,379 |  |  | $ | (133,500) |  |  | $ | 14,879 |  |  | $ | 322,137 |  |  | $ | (322,137) |  |  | $ | — |  |  | $ | 470,516 |  |  | $ | (455,637) |  |  | $ | 14,879 |
The effect of foreign currency exchange in the table above reflects the impact on goodwill of amounts recorded in currencies other than the U.S. dollar on the financial statements of foreign subsidiaries and the resulting effect of foreign currency translation between the applicable functional currency and the U.S. dollar. Impairment of Goodwill During the Year Ended December 31, 2024 All goodwill reported as of December 31, 2024 and December 31, 2023 is included in our Healthcare Solutions reportable segment, which is also the reporting unit to which all goodwill is assigned for purposes of goodwill impairment testing. We performed a qualitative impairment assessment related to the goodwill assigned to this reporting unit as of November 1, 2024, our annual goodwill impairment testing date, and this assessment did not result in a goodwill impairment charge. However, as previously discussed in Note 2, we previously performed an interim period quantitative goodwill impairment test as of September 30, 2024 and, upon completion of this interim period test, the Company concluded that the carrying value of the Healthcare Solutions reporting unit exceeded its fair value by $101.4 million, after adjustment for long-lived asset impairment charges described in Note 7, Note 8 and Note 11. The results of our interim period impairment test primarily reflected lower forecasted cash flows prepared for the reporting unit in connection with the Company's most recently commenced annual long-range planning process, as compared to the cash flow forecasts prepared for purposes of the prior annual goodwill impairment test performed as of November 1, 2023. Consistent with the results of our interim period goodwill impairment test, our results for the year ended December 31, 2024 include a $101.4 million goodwill impairment charge that is reported within asset impairment charges on our consolidated statements of operations. Impairment of Goodwill During the Year Ended December 31, 2023 For the year ended December 31, 2023, we completed the required annual goodwill impairment test for each of our reporting units (Healthcare Solutions and Industrial Solutions) as of November 1, 2023, as further discussed in Note 2. The goodwill impairment tests that we performed compared the fair value of each of our reporting units to its carrying value. We estimated the fair value of each reporting unit based upon projections of future revenues, expenses, and cash flows discounted to their present value. As a result of this goodwill impairment test, we determined that the carrying value of our Industrial Solutions reporting unit exceeded its fair value by an amount that was in excess of the goodwill assigned to the Industrial Solutions reporting unit. This result of our impairment test is primarily attributable to (1) the significant and sustained decline in the trading price of our common stock and our market capitalization leading up to and as of November 1, 2023 and (2) the significantly higher carrying value (including the goodwill balance) of the Industrial Solutions reporting unit, as compared to the Healthcare Solutions reporting unit. We recognized a goodwill impairment charge of $279.8 million to write off the entire goodwill balance assigned to the Industrial Solutions reporting unit for the year ended December 31, 2023. This goodwill charge is reported within asset impairment charges on our consolidated statement of operations. The estimated fair value of our Healthcare Solutions reporting unit was in excess of its carrying value as of November 1, 2023.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration